In brief
In a surprising turn, five-time Grand Slam champion Iga Swiatek has been handed a one-month suspension after testing positive for the heart medication trimetazidine (TMZ). The Polish player was tested out-of-competition in August 2024 while she was ranked world number one. The International Tennis Integrity Agency (ITIA) confirmed that the positive result came from a contaminated regulated medication, concluding that Swiatek was not at fault. Despite this ruling, her provisional suspension led to her missing three major tournaments. Swiatek accepted the ITIA's one-month sanction and will be eligible to compete again on December 4, 2024. This unusual case raises concerns about the impact of medication contamination in sports.
Iga Swiatek Accepts One-Month Doping Suspension World tennis star Iga Swiatek faces suspension due to a positive doping test for a regulated heart medication. In a surprising turn, five-time Grand Slam champion Iga Swiatek has been handed a one-month suspension after testing positive for the heart medication trimetazidine (TMZ). The Polish player was tested out-of-competition in August 2024 while she was ranked world number one. The International Tennis Integrity Agency (ITIA) confirmed that the positive result came from a contaminated regulated medication, concluding that Swiatek was not at fault. Despite this ruling, her provisional suspension led to her missing three major tournaments. Swiatek accepted the ITIA's one-month sanction and will be eligible to compete again on December 4, 2024. This unusual case raises concerns about the impact of medication contamination in sports.
